YJE-16681-46886
2 vaccinations
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 209 / MD
- Registered
- 2021-05-21
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-07
Dose 1 — Pfizer-BioNTech
-
2021-05-21
Registered in v-safe
- 2021-05-21
-
2021-05-28
Dose 2 — Pfizer-BioNTech
-
2021-05-30
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: Good · Site: Pain · Muscle or body achesFree text: 2024-05-25MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-31
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-06-01
- 2021-06-02
- 2021-06-03
- 2021-06-04
- 2021-06-11
- 2021-06-18
- 2021-06-25
- 2021-07-02
- 2021-07-09
- 2021-08-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-07 | Pfizer-BioNTech | |
| 2 | 2021-05-28 | Pfizer-BioNTech |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): 2024-05-25
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release